Macroeconomic Monitor

2017.12.05

Reform for more accessible and cheaper medicines in Bulgaria

cheap drugs

|Full text of the analysis| Summary and conclusions from the analysis of the sartan group: The results of this study confirm the conclusions of previous analyses, such as the World Bank's 2015 analysis, as well as good practices from EU countries, and quantify the positive effects of implementing a progeneric policy within the framework of …

More »